Adalimumab/etanercept/infliximabVarious toxicities: 6 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1853卷 / 1期

关键词：

D O I：

10.1007/s40278-021-94885-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：19 / 19

相关论文

共 50 条

[41] Adalimumab/etanercept/infliximabPsoriasis: 6 case reports
Reactions Weekly, 2013, 1438 (1) : 5 - 5
[42] Adalimumab/etanercept/infliximabTuberculosis: 6 case reports
Reactions Weekly, 2017, 1672 (1) : 15 - 15
[43] Adalimumab/etanercept/infliximabTuberculosis: 6 case reports
Reactions Weekly, 2017, 1670 (1) : 15 - 15
[44] InfliximabVarious toxicities: 5 case reports
Reactions Weekly, 2018, 1714 (1) : 230 - 230
[45] InfliximabVarious toxicities: 3 case reports
Reactions Weekly, 2015, 1569 (1) : 131 - 131
[46] InfliximabVarious toxicities: 8 case reports
Reactions Weekly, 2019, 1762 (1) : 214 - 214
[47] InfliximabVarious toxicities: 5 case reports
Reactions Weekly, 2021, 1872 (1) : 259 - 259
[48] InfliximabVarious toxicities: 3 case reports
Reactions Weekly, 2018, 1731 (1) : 144 - 144
[49] InfliximabVarious toxicities: 5 case reports
Reactions Weekly, 2019, 1783 (1) : 145 - 145
[50] InfliximabVarious toxicities: 17 case reports
Reactions Weekly, 2017, 1657 (1) : 239 - 239

← 1 2 3 4 5 →